Quick Answer
CNBX Pharmaceuticals Inc. reported Gross Profit of $5.7 thousand for the year ending 2017.
- CNBX Pharmaceuticals Inc. showed a decrease of -94.9% in Gross Profit from 2016 to 2017.
- This data is from CNBX Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on December 8, 2017.
- XBRL data for this metric is available from 2015 to 2017 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $0.00 | Q2 2015: $0.00 | Q1 2016: $12.5 thousand | Q2 2016: $50.0 thousand | Q4 2016: $0.00 | Q1 2017: $1.2 thousand | Q2 2017: $1.6 thousand | Q4 2017: $1.8 thousand | Q1 2018: $1.9 thousand | Q4 2018: $3.3 thousand | Q1 2023: $0.00 | Q1 2024: $34.4 thousand | Q1 2025: $0.00.
- Historical annual values: Fiscal year 2017: $5.7 thousand | Fiscal year 2016: $112.5 thousand | Fiscal year 2015: $0.00.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: